One of the best performing spaces within the healthcare space has been companies looking to develop small molecule drugs to treat various forms of cancer. With tens of billions of dollars being poured into cancer research each year, the companies involved in this space are attempting to create the next breakthrough therapy that can help alleviate suffering for many patients around the world. One such company, CytRx Corporation (CYTR), appears poised for greatness but it hasn't participated in the cancer rally over the past few years which begs the question, why not? It appears the market has simply forgotten about CytRx while the major players continue to soar in value. Is this a problem or an opportunity?...
CytRx Corporation Remains An Undiscovered Opportunity In The Cancer Space
Sep 18 2013, 08:12 | about: CYTR
BOOKMARKED / READ LATER
Added to your bookmarks on the Seeking Alpha homepage